Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1166, 2007-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Permax withdrawn from Chinese market
Reactions Weekly, Vol. 1, Iss. 1163, 2007-01 ,pp. :
Access to resources
Recommend
Nefazodone to be withdrawn from Canadian market
Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. :
Pharmacogenetics of drugs withdrawn from the market
By Zhang Wei Roederer Mary W Chen Wang-Qing Fan Lan Zhou Hong-Hao
Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. :
Dextropropoxyphene products withdrawn from US market
Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. :
Canadian Permax label change: risk of cardiac valvulopathy
Reactions Weekly, Vol. 1, Iss. 1026, 2004-01 ,pp. :